Ruoxi Pi
Senior Scientist ImmuneBridge
Ruoxi Pi is an immunologist who has a longstanding passion in developing therapeutic strategies to treat cancer and infectious diseases by harnessing the power of immune responses.
During her postdoctoral training in Stanford University, she investigated how human NK cells respond to HIV infection and developed novel NK cell engineering strategies for overcoming hurdles of a functional cure. Now she is applying her immunology and cell engineering skills to develop off-the-shelf NK cell products for treating cancer. BS: Zhejiang University, PhD: Yale University.
Seminars
Tuesday 8th December 2026
Harnessing Elite Donor Selection Strategies to Enhance HSC-Derived NK Cell Manufacturing Performance
1:45 pm
- Identifying high-performing donor characteristics to generate potent, consistent HSCderived NK cell products at scale
- Implementing donor screening and qualification frameworks to improve manufacturing success rates and reduce variability
- Leveraging donor-derived cellular attributes alongside expansion technologies to enhance therapeutic efficacy and commercial readiness
